Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.63 |
| ▸ | MAOB | P27338 | 7/20 | 0.63 |
| ▸ | S100A4 | P26447 | 1/20 | 0.56 |
| ▸ | PPOX | P50336 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | TDP2 | O95551 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PTPRC | P08575 | 1/20 | 0.48 |
| ▸ | BCL2 | P10415 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL11426699 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL11422269 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| Potassium SCHEMBL31268252 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| Potassium SCHEMBL11435320 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL11435308 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL11422278 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL11426691 | 0.98 | MAOA (0.61) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL25319107 | 0.83 | TDP2 (0.49) | MAOAMAOBS100A4PPOXTGM2 | |
| SCHEMBL24665688 | 0.82 | TGM2 (0.68) | MAOAMAOBS100A4TGM2CES1 | |
| Hydrochloric Acid SCHEMBL2098566 | 0.81 | TDP2 (0.47) | MAOAMAOBS100A4PPOXTGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496072-A | Method for preparing 2-butanone by biomimetic catalytic oxidation of n-butane | 浙江工业大学 | 2024-08-16 | — | — | CN | claimed |
| CN-118146084-A | Method for preparing benzoic acid and coproducing epsilon-caprolactone by biomimetically catalyzing air to oxidize toluene and cyclohexanone | 广西大学 | 2024-06-07 | — | — | CN | claimed |
| CN-108117645-B | Method for preparing polyaryl imide and production device thereof | 北京鼎益新材科技有限公司 | 2020-08-14 | — | — | CN | claimed |
| US-7112586-B2 | Substituted diamine derivatives useful as motilin antagonists | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2006-09-26 | — | — | US | claimed |
| US-6967199-B2 | Substituted diamine derivatives useful as motilin antagonists | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2005-11-22 | — | — | US | claimed |
| US-20050148584-A1 | Novel substituted diamine derivatives useful as motilin antagonists | JOHNSON SIGMOND G (US) | 2005-07-07 | — | — | US | claimed |
| US-20030203906-A1 | A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder | JOHNSON SIGMONG G (US) | 2003-10-30 | — | — | US | claimed |
| EP-1294695-A2 | SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-03-26 | — | — | EP | claimed |
| US-20020013352-A1 | For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2002-01-31 | — | — | US | claimed |
| WO-2001085694-A2 | SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-11-15 | — | — | WO | claimed |
| US-4256507-A | FLAVANTHRONE, PYRANTHRONE, INDANTHRONE, INDIGO, QUINACRIDONE, PERYLENE DIANHYDRIDE OR DIIMIDE PIGMENTS SUBSTITUTED WITH PHTHALIMIDO-METHYL GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | claimed |
| EP-0014458-A1 | Pigment preparations for lacquers and printing dyes | BASF Aktiengesellschaft (DE) | 1980-08-20 | — | — | EP | claimed |
| US-4181530-A | ELECTRON ATTRACTING PHTHALIMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-01 | — | — | US | claimed |
| WO-2026098560-A2 | BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-20260125378-A2 | Heterocyclic Compounds | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| CN-121824360-A | Preparation method of 4-sulfophthalonitrile | 沈阳化工研究院有限公司 | 2026-04-10 | — | — | CN | disclosed |
| US-4181530-A | ELECTRON ATTRACTING PHTHALIMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4144072-A | CONTAINING A PHTHALAZINONE AND A PHTHALIMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-03-13 | — | — | US | disclosed |
| US-4140532-A | ORGANIC SILVER SALT, CATALYST, REDUCING AGENT, 2H-1,3-BENZOTHIAZIN-2,4(3H-)DIONE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-02-20 | — | — | US | disclosed |
| US-4065471-A | N-(4-Amino-2-butynyl)imides | STERLING DRUG INC. (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125378-A2 | Heterocyclic Compounds | NFATC1, CD4, MALT1 | MAOA 2893/4885MAOB 2174/4885S100A4 1967/4885 |
| US-20020013352-A1 | For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder | MLNR, GIPR, NPY1R | MAOA 526/4885MAOB 383/4885S100A4 3793/4885 |
| US-20030203906-A1 | A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder | MLNR, GIPR, NPY1R | MAOA 434/4885MAOB 508/4885S100A4 4196/4885 |
| US-20050148584-A1 | Novel substituted diamine derivatives useful as motilin antagonists | MLNR, NPY4R, GIPR | MAOA 520/4885MAOB 456/4885S100A4 2846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.